Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary – Procter & Gamble Health Limited** The company faces critical compliance exposure with a perfect 10.0/10 compliance risk score under SEBI BRSR Core Expansion requirements, creating potential enforcement action and delisting risk given its ₹934.2 crore revenue scale. Extended Producer Responsibility (EPR) obligations present the second-largest financial exposure at 6.5/10 risk intensity—with EPR applicability status unknown and estimated compliance costs of ₹2–6 crore annually, plus potential penalties for non-compliance under India's plastic waste rules. The absence of reported Scope 1 and Scope 2 emissions data (both at 0 tCO2e) is inconsistent with a healthcare manufacturing facility and suggests either material disclosure gaps or incomplete emissions accounting, creating regulatory and reputational risk. Immediate priority: clarify EPR registration status and quantify actual emissions to resolve compliance gaps before SEBI enforcement escalation.
Source: Procter & Gamble Health Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.